Insider digest · AMGN
Amgen insider filings, Nov 9, 2026
Amgen insiders filed 4 routine Form 4 reports on Nov 9, 2026: awards. None of them was a purchase or a sale in the market. This page groups them in one place; each row links to the filing note, and each number links to the Form 4 itself.
What the codes mean: how to read a Form 4 · stock-based compensation.
Stock awards and grants
Shares or units the company granted as pay. No shares were bought or sold in the market. Total for the day: 729 shares or units.
| Person | Code | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Michael V. Drake · director | A | Common Stock | 114.026 | – | – | 6,030 |
| David W. Gibbs · director | A | Common Stock | 278 | – | – | 278 |
| Charles M. Holley · director | A | Common Stock | 184.614 | – | – | 13,262 |
| Omar Ishrak · director | A | Common Stock | 152.035 | – | – | 7,682 |
The filings
- Amgen director Michael V. Drake reports an award of about 114 shares · SEC filing index
- Amgen director David W. Gibbs reports an award of 278 shares · SEC filing index
- Amgen director Charles M. Holley reports an award of about 185 shares · SEC filing index
- Amgen director Omar Ishrak reports an award of about 152 shares · SEC filing index
Amgen company file → · All Amgen filings notes
Disclosures
- Editor holdings in AMGN
- The editor holds no position in Amgen (AMGN). As of Nov 11, 2026.
- Compensation
- Nobody paid for this page. No affiliate links.
A summary of public filings for general education, the same for every reader. Not a recommendation to buy, sell or hold AMGN.